Schedule 13D ownership disclosure

CG oncology Inc

Common Stock, par value $0.0001 per share · CUSIP: 156944100

Event date: 2025-09-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Seven Fleet Partners LPReported CIK 0002059170

    Shares: 1,515,151 · Class: 1.9%

  • Seven Fleet Advisors LLC

    Shares: 1,515,151 · Class: 1.9%

  • Brian Liu

    Shares: 1,515,151 · Class: 2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-25-001163
Form type
SCHEDULE 13D
Filer
CG Oncology, Inc.
CIK
CIK 1991792
Filed
Sep 18, 2025
Reporting period
Sep 11, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub